Title

Incidence of bleeding complications associated with abciximab use in conjunction with thrombolytic therapy in patients requiring percutaneous transluminal coronary angioplasty.

Publication/Presentation Date

6-1-1999

Abstract

The use of abciximab after full-dose failed thrombolytics within 15 hours of acute myocardial infarction significantly increases the risk of major bleeding complications.

Volume

83

Issue

11

First Page

1569

Last Page

1571

ISSN

0002-9149

Disciplines

Medicine and Health Sciences

PubMedID

10363875

Department(s)

Department of Medicine, Cardiology Division

Document Type

Article

Share

COinS